253 related articles for article (PubMed ID: 7723750)
1. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
2. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
3. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of cloned human bombesin receptors.
Benya RV; Kusui T; Pradhan TK; Battey JF; Jensen RT
Mol Pharmacol; 1995 Jan; 47(1):10-20. PubMed ID: 7838118
[TBL] [Abstract][Full Text] [Related]
5. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
[TBL] [Abstract][Full Text] [Related]
6. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
7. Systematic development of bombesin/gastrin-releasing peptide antagonists.
Coy DH; Jensen RT; Jiang NY; Lin JT; Bogden AE; Moreau JP
J Natl Cancer Inst Monogr; 1992; (13):133-9. PubMed ID: 1389686
[TBL] [Abstract][Full Text] [Related]
8. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
9. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
10. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
[TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
Benya RV; Fathi Z; Kusui T; Pradhan T; Battey JF; Jensen RT
Mol Pharmacol; 1994 Aug; 46(2):235-45. PubMed ID: 8078487
[TBL] [Abstract][Full Text] [Related]
12. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
13. Effects of bombesin and gastrin-releasing peptide on human bronchial epithelial cells from a series of donors: individual variation and modulation by bombesin analogs.
Siegfried JM; Guentert PJ; Gaither AL
Anat Rec; 1993 May; 236(1):241-7. PubMed ID: 8507011
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
16. Bombesin-like peptide receptor subtypes promote mitogenesis, which requires persistent receptor signaling.
Feldman RI; Bartholdi MF; Wu JM
Mol Pharmacol; 1996 Nov; 50(5):1346-54. PubMed ID: 8913367
[TBL] [Abstract][Full Text] [Related]
17. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
18. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
Mantey SA; Coy DH; Entsuah LK; Jensen RT
J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
[TBL] [Abstract][Full Text] [Related]
19. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
Feldman RI; Fried S; Mann E; Wu JM; Liang M
Mol Pharmacol; 1996 Mar; 49(3):505-14. PubMed ID: 8643090
[TBL] [Abstract][Full Text] [Related]
20. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
